4//SEC Filing
Anevski Peter 4
Accession 0001628280-23-025068
CIK 0001551306other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:27 PM ET
Size
10.5 KB
Accession
0001628280-23-025068
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Anevski Peter
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-07-14$3.95/sh+17,990$71,061→ 225,937 total - Sale
Common Stock
2023-07-14$38.95/sh−17,990$700,711→ 207,947 total - Sale
Common Stock
2023-07-14$38.95/sh−2,096$81,639→ 1 total(indirect: See footnote) - Exercise/Conversion
Stock Option (Right to Buy)
2023-07-14−17,990→ 715,555 totalExercise: $3.95Exp: 2029-05-23→ Common Stock (17,990 underlying)
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.74 to $39.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
- [F4]These options are fully vested and exercisable.
Documents
Issuer
Progyny, Inc.
CIK 0001551306
Entity typeother
Related Parties
1- filerCIK 0001576147
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:27 PM ET
- Size
- 10.5 KB